financetom
Business
financetom
/
Business
/
US STOCKS-Dow, S&P 500 drop ahead of earnings; investors cautious after 6 weekly gains
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US STOCKS-Dow, S&P 500 drop ahead of earnings; investors cautious after 6 weekly gains
Oct 22, 2024 12:45 PM

*

Boeing ( BA ) gains after offering new wage deal

*

Humana, Cigna ( CI ) fall after report companies resumed merger

talks

*

114 S&P 500 companies to report results this week

*

Nvidia ( NVDA ) briefly touches record high

*

Indexes: Dow down 0.85%, S&P 500 down 0.29%, Nasdaq flat

(Updated at 2:15pm ET/6:15pm GMT)

By Lisa Pauline Mattackal, Purvi Agarwal and Carolina Mandl

Oct 21 (Reuters) -

The Dow Jones Industrial Average and S&P 500 fell on Monday,

as investors awaited earnings from major companies to gauge

whether equities will sustain the recent rally that has brought

six straight weekly gains.

"It's not at all unusual for the market to want to take

a little bit of a breather after six weeks of continually record

highs," said Carol Schleif, chief investment officer at BMO

Family Office.

At 02:15 p.m. the Dow Jones Industrial Average fell

368.73 points, or 0.85%, to 42,907.18, the S&P 500 lost

17.04 points, or 0.29%, to 5,847.63 and the Nasdaq Composite

gained 11.04 points, or 0.06%, to 18,500.59.

A jump in Treasury yields added pressure, with the yield

on the benchmark 10-year bond rising as high as 4.17%, a 12-week

high.

"Rates are going up because there is a thought that

maybe the Federal Reserve won't cut two times before the year's

over. You see economic data coming in a little bit stronger than

anticipated," said David Laut, chief investment officer at

Abound Financial.

Most rate-sensitive megacap technology stocks slipped,

with Tesla down 1.3%, and Microsoft ( MSFT ) and Meta

Platforms ( META ) both losing 0.4%.

After a fairly upbeat start to earnings season, the

focus is on the 114 S&P 500 companies scheduled to report this

week. These include Tesla, Coca-Cola and Texas

Instruments ( TXN ).

Of companies that have reported so far, 83.1% beat

earnings estimates, according to data compiled by LSEG on

Friday.

Some traders were likely booking profits, Tim Ghriskey,

senior portfolio strategist with Ingalls & Snyder, said.

On Friday, the Dow and the S&P 500 both closed at record

highs as all three major indexes closed out a sixth consecutive

week of gains, their longest winning streak this year.

Monday's declines were broad, with almost all 11 major

S&P 500 sectors in the red, except for Information Technology

.

The rate-sensitive Real Estate sector dropped

1.77% as yields rose, while the technology sector was lifted by

a 3% jump in chip heavyweight Nvidia ( NVDA ), which briefly

touched a fresh record high.

The economically sensitive small-cap Russell 2000

dropped 1.4%.

Investors also looked ahead to the upcoming U.S.

presidential election, with polls showing the chances improving

for former President Donald Trump, the Republican candidate.

"As the election date approaches, even small changes in

tight polls could drive seemingly erratic swings in market

sentiment," Danske Bank analysts said.

Meanwhile, Boeing ( BA ) jumped 3.2% after news that

workers could vote on a new deal to end a costly five-week

strike.

Spirit Airlines ( SAVE ) skyrocketed 51.7% after the company

reached an agreement to extend a debt refinancing deadline by

two months.

Humana slipped 1.82% after a report said Cigna ( CI )

had resumed merger talks with the health insurer. Cigna's ( CI )

shares lost 4.32%.

Home sales, flash PMI and durable goods reports are on

the data docket through the week, as is the Fed's Beige Book.

Declining issues outnumbered advancers by a 3.83-to-1

ratio on the NYSE. There were 226 new highs and 39 new lows on

the NYSE.

The S&P 500 posted 41 new 52-week highs and 2 new lows

while the Nasdaq Composite recorded 82 new highs and 41 new

lows.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Market Chatter: NFL Looks to Pre-Approve Investors Including Ares Management, Carlyle Group
Market Chatter: NFL Looks to Pre-Approve Investors Including Ares Management, Carlyle Group
May 22, 2024
12:36 PM EDT, 05/22/2024 (MT Newswires) -- Ares Management ( ARES ) and Carlyle Group ( CG ) are among investors the National Football League is looking to pre-approve to own minority stakes in teams, Bloomberg News reported Wednesday, citing unnamed people with knowledge of the matter. Other firms include Arctos Partners, Avenue Capital Group, and CVC Capital Partners, the...
Update: Wesdome Gold Mines Loses 4% as Appoints Kevin Lonergan as Senior Vice President for Technical Services
Update: Wesdome Gold Mines Loses 4% as Appoints Kevin Lonergan as Senior Vice President for Technical Services
May 22, 2024
12:33 PM EDT, 05/22/2024 (MT Newswires) -- Wesdome Gold Mines ( WDOFF ) said Wednesday it appointed Kevin Lonergan as senior vice president for technical services, effective yesterday. Lonergan is a mining engineer with more than 25 years of executive leadership and technical expertise in the domestic and international mining industry. Before advising Wesdome, Lonergan served as vice president of...
Apple challenges $2 bln EU antitrust fine at EU court
Apple challenges $2 bln EU antitrust fine at EU court
May 22, 2024
BRUSSELS, May 22 (Reuters) - Apple ( AAPL ) has challenged at Europe's second-highest court a 1.84 billion euro ($2 billion) fine imposed by EU antitrust regulators for impeding Spotify ( SPOT ) and other streaming rivals via restrictions on its App Store, according to a court filing. Apple ( AAPL ) had already said it would appeal after the...
Biogen Agrees to Buy Human Immunology Biosciences For up to $1.8 Billion
Biogen Agrees to Buy Human Immunology Biosciences For up to $1.8 Billion
May 22, 2024
12:42 PM EDT, 05/22/2024 (MT Newswires) -- Biogen (BIIB) announced a deal to buy privately held Human Immunology Biosciences for up to $1.8 billion, expanding its rare disease pipeline with an investigational candidate that aims to treat a kidney-specific disease. The biotechnology company will pay $1.15 billion upfront and up to $650 million in potential milestone payments. Biogen's shares dipped...
Copyright 2023-2026 - www.financetom.com All Rights Reserved